Aromatase inhibitors versus tamoxifen and the risk of incident intracranial meningioma: a propensity score matching analysis of 46,408 patients
INTRODUCTION: Meningiomas are hormonally sensitive tumors that occur disproportionately among women with breast cancer. We compared the risk of incident meningioma among patients initiating aromatase inhibitors (AIs) versus tamoxifen. METHODS: Using the TriNetX Global Collaborative Network (181 healthcare organizations), we identified adults with breast cancer recorded during 2010-2015 who initiated anastrozole, letrozole, or exemestane versus tamoxifen, without exposure to the alternate endocrine therapy class. Cohorts were matched 1:1 on 27 covariates. Incident meningioma was assessed at 1, 2, and 3 years using risk estimates and Cox proportional hazards models. RESULTS: After matching, 23,204 patients were included per cohort; 23,110 AI users and 23,114 tamoxifen users without prior meningioma were included in the outcome analyses. Meningioma risk was higher with AIs at 1 year (1.51 vs 0.82 per 1,000; HR 1.846, 95% CI 1.056-3.227), 2 years (2.64 vs 1.56; HR 1.705, 95% CI 1.129-2.574), and 3 years (3.29 vs 2.29; HR 1.449, 95% CI 1.021-2.058). Absolute risk differences were 0.69, 1.08, and 1.00 per 1,000, respectively. CONCLUSION: AI initiation was associated with a modestly higher but progressively attenuating relative risk of meningioma than tamoxifen, with a small absolute excess. These findings should not alter endocrine therapy selection but may inform evaluation of new dural-based lesions in AI users.
Authors
- Brandon Peter Lucke-Wold (ORCID: https://orcid.org/0000-0001-6577-4080)
- Jeremiah Hilkiah Wijaya (ORCID: https://orcid.org/0000-0001-8771-2163)
- Made Agus Mahendra Inggas (ORCID: https://orcid.org/0000-0002-3218-3150)
- Soni Roy Kurniawan Hulu (ORCID: https://orcid.org/0009-0005-7502-7448)
- Vivien Puspitasari (ORCID: https://orcid.org/0000-0002-3904-249X)
Institutions
- Rutgers, The State University of New Jersey (US)
- Pelita Harapan University (ID)
- University of Arizona (US)
- Rutgers New Jersey Medical School (US)
- Taipei Medical University (TW)
Publication Details
- Journal
- Cancer Causes & Control
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s10552-026-02277-3
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00